Recruiting

Observational Study

Sponsor:

University of British Columbia

Code:

NCT04366388

Conditions

Frail Elderly Syndrome

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

ActivPAL3 VT (PAL Technologies Ltd).

Study Details

Brief summary:

The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.

Conditions

Frail Elderly Syndrome

Study ID

NCT04366388

Start date

Jun 1, 2022

Status verified date

Apr, 2026

Completion date

Dec, 2026

Anticipated

Primary completion date

Dec, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • be 65 years of age or older
  • be admitted in ACE Unit

Exclusion Criteria:

  • be less than 65 years of age
  • be nonambulatory
  • be diagnosed with end-stage organ failure (end-stage COPD, renal failure requiring dialysis, end-stage heart failure)

Study Design

Enrollment

120 participants

Anticipated

Interventions and Outcome Measures

Arms

Frail hospitalized old adults

Over than 65-years of age Admitted into Acute Unit Nonambulatory

Interventions

ActivPAL3 VT (PAL Technologies Ltd).

. The ActivPAL will be fitted by a trained research assistant on the mid-thigh of the participants' dominant leg. ActivPALs have an inclinometer that detects the joint angle of the thigh to capture lying, sitting, standing, and stepping activities.

Primary outcome measure

  • Total standing time [ Time Frame: 2 weeks or shorter ]

Central Contacts and Locations

Central contacts

Boris Feldman

604-575-5115boris.feldman@vch.ca

Locations

Gerontology Research Lab, Dept. of Medicine, Vancouver Coastal Health Research Institute, VGH Research Pavilion, Room 186-828 West 10th Avenue

Recruiting

Vancouver, British Columbia, Canada, V5Z 1M9

Contacts

Boris Feldman

604-875-5115boris.feldman@vch.ca

Kenneth Madden, MD

604-875-4931kmmadden@mail.ubc.ca

Principal Investigator:

Kenneth M Madden, MD MSc FRCPC

More Information

Sponsor

University of British Columbia

Last update posted

May 1, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of British Columbia on 2026-05-01.